Search Results for "B.com Part II Results 2009 Private"

19:42 EDT 3rd July 2015 | BioPortfolio

Matching Channels

KIACTA

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

The Asymptomatic Patient With Abnormal Laboratory Test Results

MatBA - Mature B-cell neoplasm array

Mature B-cell neoplasms arise in B-cells that have entered germinal centers within lymph nodes as part of the immune response. They display great heterogeneity at the clinical, pathologic, and genet...

SureSeq Solid Tumour Panel Sequencing Service

The SureSeq Solid Tumour Panel Sequencing Service utilises an enrichment panel comprising the full coding regions of 58 prioritised cancer genes. The aim of the panel is to improve cancer care by pr...

Tricuspid Regurgitation

Tricuspid regurgitation (tricuspid incompetence, tricuspid insufficiency) is leakage of blood backward through the tricuspid valve each time the right ventricle contracts.Tricuspid regurgitation is ...

Matching News

PTV News: Oct 29, 2009

Top stories on October 29th, 2009: Emerging markets and swine flu ramp GSK profits Sanofi's cancer deal with Micromet Vertex Hep C drug boasts impressive trial results Tysabri test for PML risk ...

PTV News: Oct 5, 2009

Top stories on October 5th, 2009: BMS Dapagliflozen aces phase III Potential RVO indication for Lucentis Novel intracellular drug delivery system Healthcare’s ‘perfect storm’ part 2 Na...

PTV News: Oct 22, 2009

Top stories on October 22nd, 2009: Novartis bullish with or without vaccine windfall Mixed results from diabetes trials Self-service Herceptin to save money, time and stress The Middle East's emer...

PTV News: Oct 14, 2009

Top stories on October 14th, 2009: GSK'S move into orphan drugs Merck's Indian bioscience buyout J&J results underwhelm the market Gout chemical "slows Parkinson's progression" GSK nurtures ...

Rates of Psychiatrists’ Participation in Health Insurance Networks

JAMA PsychiatryAcceptance of Insurance by Psychiatrists and the Implications for Access to Mental Health CareTara F. Bishop, MD, MPH; Matthew J. Press, MD, MSc; Salomeh Keyhani, MD, MPH; Harold Alan P...

PTV News: Oct 30, 2009

Top stories on October 30th, 2009: Biotech IPO - can Aldagen float despite losses? Richter/Forest antipsychotic posts good results Statins: new evidence they can help you survive flu Transcept to ...

Part 1: 2009 and Biotech Financing: How To Stay Afloat in Turbulent Economic Waters

2009 is a tough year in the business world and for many biotech companies finding essential funding is proving to be harder than ever. In this comprehensive discussion Paul Hastings, CEO, OncoMed Phar...

Part 2: 2009 and Biotech Financing: How To Stay Afloat in Turbulent Economic Waters

2009 is a tough year in the business world and for many biotech companies finding essential funding is proving to be harder than ever. In this comprehensive discussion Paul Hastings, CEO, OncoMed Phar...

Matching PubMed Articles

Retirement patterns of Australian doctors aged 65 years and older.

Objective To investigate retirements over a 4-year period among Australian general practitioners (GPs) and specialists aged 65 years and over, and factors influencing retirement.Methods Data from Medi...

ACO contracting with private and public payers: a baseline comparative analysis.

Objectives The accountable care organization (ACO) model is currently being pursued by private insurers, as well as federal and state governments. Little is known, however, about the prevalence of pri...

Public private partnership in vascular surgery.

Objective To describe and analyze the results of a public-private partnership between the Ministry of Health and a private hospital in a project of assistance and scientific research in the field of e...

Stalking of social healthcare workers: preliminary results of a study conducted by the region of Apulia, Italy.

Aim. This study has the aim to represent the degree of information/training about the identification of possible stalking acts and their frequency, within the context of public and private National He...

The social nature of benevolent sexism and the antisocial nature of hostile sexism: Is benevolent sexism more likely to manifest in public contexts and hostile sexism in private contexts?

Previous research converges on demonstrating that benevolent sexism (BS) is socially approved, whereas hostile sexism (HS) is socially disapproved. We postulated that a sample of married women would b...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement